Delivery Order SPE2DB22D3501-SPE2DB26FTH93
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $17,854.65, with completion scheduled for October 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of July 15, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger procurement relationship with the federal government. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion scheduled for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-competitive, non-set-aside award is scheduled for completion by October 22, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction under AmerisourceBergen's larger federal contract portfolio supporting military and defense healthcare...
- The Defense Logistics Agency awarded a $3,449 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive, firm fixed-price delivery order will be fulfilled at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,415.98. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by October 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a competitive award, this delivery order reflects the company's demonstrated capability...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH93Delivery Order
The Defense Logistics Agency awarded a $3,449 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price contract, with an ultimate completion date of November 3, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare systems. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements for specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/31/25 |